Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Casey's General Stores
CASY
$30.9B
| $26.6M | ﹤0.01% |
206,029
+61,289
| +42% | +$7.05M |
|
1552
Rocket Pharmaceuticals
RCKT
$394M
| $26.4M | ﹤0.01% |
+1,072,199
| New | +$23.3M |
|
|
STKL
1553
DELISTED
SunOpta
STKL
| $26.3M | ﹤0.01% |
3,583,533
+323,483
| +10% | +$2.58M |
|
1554
UroGen Pharma
URGN
$2.29B
| $26.3M | ﹤0.01% |
556,003
-150,611
| -21% | -$7M |
|
1555
iShares S&P 100 ETF
OEF
$20.6B
| $26.2M | ﹤0.01% |
202,043
-4,245
| -2% | -$537K |
|
1556
Hope Bancorp
HOPE
$1.79B
| $26.2M | ﹤0.01% |
1,619,159
+12,439
| +0.8% | +$215K |
|
1557
Insight Enterprises
NSIT
$4.38B
| $26.2M | ﹤0.01% |
483,641
+120,810
| +33% | +$6.35M |
|
1558
Voyager Therapeutics
VYGR
$201M
| $26.1M | ﹤0.01% |
1,379,762
-952,459
| -41% | -$18.3M |
|
|
STML
1559
DELISTED
Stemline Therapeutics, Inc.
STML
| $25.8M | ﹤0.01% |
1,553,548
-439,493
| -22% | -$7.05M |
|
|
OBSV
1560
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $25.8M | ﹤0.01% |
1,429,562
-370,543
| -21% | -$5.45M |
|
1561
John Wiley & Sons Class A
WLY
$2.66B
| $25.7M | ﹤0.01% |
424,895
+56,050
| +15% | +$3.49M |
|
|
HIBB
1562
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $25.7M | ﹤0.01% |
1,369,507
+32,545
| +2% | +$737K |
|
|
MCRN
1563
DELISTED
Milacron Holdings Corp.
MCRN
| $25.7M | ﹤0.01% |
1,270,864
+6,963
| +0.6% | +$141K |
|
1564
Enovis
ENOV
$1.53B
| $25.7M | ﹤0.01% |
413,691
-419,616
| -50% | -$23.9M |
|
|
ESND
1565
DELISTED
Essendant Inc.
ESND
| $25.7M | ﹤0.01% |
2,002,763
-71,940
| -3% | -$1.03M |
|
1566
ICL Group
ICL
$6.85B
| $25.7M | ﹤0.01% |
+4,205,552
| New | +$22.3M |
|
|
BPY
1567
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $25.6M | ﹤0.01% |
+1,226,345
| New | +$24.5M |
|
1568
Vanda Pharmaceuticals
VNDA
$302M
| $25.6M | ﹤0.01% |
1,116,454
-195,017
| -15% | -$3.98M |
|
|
VRE
1569
DELISTED
Veris Residential
VRE
| $25.5M | ﹤0.01% |
1,197,600
-29,000
| -2% | -$591K |
|
|
CEO
1570
DELISTED
CNOOC Limited
CEO
| $25.4M | ﹤0.01% |
128,538
-3,083
| -2% | -$523K |
|
|
CCI.PRA
1571
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $25.2M | ﹤0.01% |
23,394
+2,394
| +11% | +$2.59M |
|
1572
iShares Short Maturity Bond ETF
NEAR
$4.85B
| $25M | ﹤0.01% |
+498,807
| New | +$25M |
|
1573
Carvana
CVNA
$77.9B
| $25M | ﹤0.01% |
2,113,260
-3,695,420
| -64% | -$39.6M |
|
|
RPT
1574
Rithm Property Trust
RPT
$93.7M
| $24.9M | ﹤0.01% |
315,970
| – | – |
|
1575
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $24.9M | ﹤0.01% |
219,931
-10,989
| -5% | -$1.25M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.